114 related articles for article (PubMed ID: 7536975)
1. Outcome of lymphocyte subsets and cytokines during combined CD4/anti-IL-2R monoclonal antibody therapy in kidney transplantation.
Racadot E; Mousson C; Tanter Y; Wijdenes J; Rifle G; Herve P
Transplant Proc; 1995 Apr; 27(2):1672-3. PubMed ID: 7536975
[No Abstract] [Full Text] [Related]
2. Monocyte modulation of endothelial leukocyte adhesion molecules.
Weill D; Wautier JL; Dosquet C; Wautier MP; Carreno MP; Boval B
J Lab Clin Med; 1995 Jun; 125(6):768-74. PubMed ID: 7539477
[TBL] [Abstract][Full Text] [Related]
3. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
de Waal Malefyt R; Yssel H; de Vries JE
J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
[TBL] [Abstract][Full Text] [Related]
4. Expression of adhesion molecules and their ligands in acute rejection of human kidney allografts.
von Willebrand E; Krogerus L; Salmela K; Isoniemi H; Häyry P; Laakkonen M; Lautenschlager I
Transplant Proc; 1995 Feb; 27(1):917-8. PubMed ID: 7533438
[No Abstract] [Full Text] [Related]
5. Expression of tumor necrosis factor and tissue adhesion molecules in the failed renal allograft.
Huang MT; Huang TW; Lee PH; Chung YC; Hu RH; Lee CS
Transplant Proc; 1994 Aug; 26(4):2181-3. PubMed ID: 7520626
[No Abstract] [Full Text] [Related]
6. Expansion of CD4+CD7- T helper cells with a TH0-TH2 function in kidney transplant recipients.
Barrou B; Legac E; Blanc C; Bitker MO; Luciani J; Chatelain C; Debré P; Autran B
Transplant Proc; 1995 Apr; 27(2):1676-7. PubMed ID: 7536977
[No Abstract] [Full Text] [Related]
7. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
[TBL] [Abstract][Full Text] [Related]
8. New immunosuppressive therapies in renal transplantation: monoclonal antibodies.
Buhaescu I; Segall L; Goldsmith D; Covic A
J Nephrol; 2005; 18(5):529-36. PubMed ID: 16299678
[TBL] [Abstract][Full Text] [Related]
9. CD4 and CD25 monoclonal antibody cocktail in kidney transplant rejection prophylaxis: clinical results of a pilot study.
Mousson C; Tanter Y; Racadot E; Wijdenes J; Chalopin JM; Chevet D; Hervé P; Rifle G
Transplant Proc; 1995 Apr; 27(2):1727-8. PubMed ID: 7725472
[No Abstract] [Full Text] [Related]
10. Molecular activation markers in rejection diagnosis.
von Willebrand E; Häyry P; Taskinen E
Transplant Proc; 1996 Feb; 28(1):484-5. PubMed ID: 8644321
[No Abstract] [Full Text] [Related]
11. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
12. Biological reagents for immunosuppressants.
Soulillou JP
Transplant Proc; 1995 Feb; 27(1):106-8. PubMed ID: 7878803
[No Abstract] [Full Text] [Related]
13. Expansion and tissue infiltration of an allospecific CD4+CD25+CD45RO+IL-7Ralphahigh cell population in solid organ transplant recipients.
Codarri L; Vallotton L; Ciuffreda D; Venetz JP; Garcia M; Hadaya K; Buhler L; Rotman S; Pascual M; Pantaleo G
J Exp Med; 2007 Jul; 204(7):1533-41. PubMed ID: 17591854
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory cytokines up-regulate intercellular adhesion molecule-1 expression on primary cultured mouse hepatocytes and T-lymphocyte adhesion.
Morita M; Watanabe Y; Akaike T
Hepatology; 1994 Feb; 19(2):426-31. PubMed ID: 7904980
[TBL] [Abstract][Full Text] [Related]
15. Progress in monoclonal antibodies in clinical transplantation.
Cosimi AB
Transplant Proc; 1994 Aug; 26(4):1943-4. PubMed ID: 7915057
[No Abstract] [Full Text] [Related]
16. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
[TBL] [Abstract][Full Text] [Related]
17. Role of tumor endothelium in CD4+ CD25+ regulatory T cell infiltration of human pancreatic carcinoma.
Nummer D; Suri-Payer E; Schmitz-Winnenthal H; Bonertz A; Galindo L; Antolovich D; Koch M; Büchler M; Weitz J; Schirrmacher V; Beckhove P
J Natl Cancer Inst; 2007 Aug; 99(15):1188-99. PubMed ID: 17652277
[TBL] [Abstract][Full Text] [Related]
18. A comparative study into the mechanisms of action of anti-tumor necrosis factor alpha, anti-CD4, and combined anti-tumor necrosis factor alpha/anti-CD4 treatment in early collagen-induced arthritis.
Marinova-Mutafchieva L; Williams RO; Mauri C; Mason LJ; Walmsley MJ; Taylor PC; Feldmann M; Maini RN
Arthritis Rheum; 2000 Mar; 43(3):638-44. PubMed ID: 10728758
[TBL] [Abstract][Full Text] [Related]
19. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
[TBL] [Abstract][Full Text] [Related]
20. Effect of anti-IL-2-receptor monoclonal antibody BT 563 in treatment of acute interstitial renal rejection.
Carl S; Wiesel M; Daniel V; Staehler G
Transplant Proc; 1995 Feb; 27(1):854-5. PubMed ID: 7879205
[No Abstract] [Full Text] [Related]
[Next] [New Search]
